I am working with primary human fibroblasts from patients with severe metabolic disease. I am interested in using RNA/mRNA re-programming of these fibroblasts in order to obtain iPSCs for downstream functional characterisation.

In recent years, numerous kits/protocols have cropped up purporting to tackle this issue. I was wondering if you could share your experience of this approach and which method you found most effective?

Many thanks,

Rob.

More Robert Flynn's questions See All
Similar questions and discussions